[Current therapy of chronic myeloid leukemia].;Kroonisen myelooisen leukemian nykyhoito.

Duodecim; lääketieteellinen aikakauskirja

Volumn 128, Issue 6, 2012, Pages 579-588

  Koskela, Hanna ^a   Koskenvesa, Perttu ^a   Mustjoki, Satu ^a   Porkka, Kimmo ^a  

^a Hematologinen tutkimusyksikkö ^*

Author keywords

[No Author keywords available]

Indexed keywords

4 METHYL N (3 (4 METHYLIMIDAZOL 1 YL) 5 (TRIFLUOROMETHYL)PHENYL) 3 ((4 PYRIDIN 3 YLPYRIMIDIN 2 YL)AMINO)BENZAMIDE; 4-METHYL-N-(3-(4-METHYLIMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-3-((4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO)BENZAMIDE; DASATINIB; IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

CHRONIC MYELOID LEUKEMIA; HUMAN; REVIEW;

HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; THIAZOLES;

EID: 84860791099     PISSN: 00127183     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)